CLINICAL TRIALS PROFILE FOR AMBIEN

All Clinical Trials for AMBIEN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00042146 ↗	Behavioral and Pharmacological Treatment for Insomnia	Completed	National Institute of Mental Health (NIMH)	Phase 4	2001-12-01	This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
NCT00042146 ↗	Behavioral and Pharmacological Treatment for Insomnia	Completed	Laval University	Phase 4	2001-12-01	This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.
NCT00044629 ↗	Combined Behavioral/Pharmacological Therapy for Insomnia	Completed	National Institute of Mental Health (NIMH)	Phase 2	2001-09-01	This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00044629 ↗	Combined Behavioral/Pharmacological Therapy for Insomnia	Completed	Duke University	Phase 2	2001-09-01	This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00086281 ↗	Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients	Completed	Jazz Pharmaceuticals	Phase 4	2003-11-01	To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg administered the morning prior to Xyrem, positive control (zolpidem 10 mg), and placebo on the frequency and outcome of events of sleep-disordered breathing in patients with obstructive sleep apnea syndrome (OSAS).
NCT00156533 ↗	Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing	Completed	Sanofi-Synthelabo	Phase 4	2005-03-01	We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped.
NCT00156533 ↗	Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing	Completed	University of Rochester	Phase 4	2005-03-01	We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped.

Clinical Trial Conditions for AMBIEN

Condition Name

Condition Name for AMBIEN
Intervention	Trials
Healthy	9
Insomnia	8
Sleep	4
Sleep Initiation and Maintenance Disorders	4

Condition MeSH

Condition MeSH for AMBIEN
Intervention	Trials
Sleep Initiation and Maintenance Disorders	20
Depression	5
Sleep Wake Disorders	3
Parasomnias	3

Clinical Trial Locations for AMBIEN

Trials by Country

Trials by Country for AMBIEN
Location	Trials
United States	73
Canada	4
India	2
Argentina	1
Germany	1

Trials by US State

Trials by US State for AMBIEN
Location	Trials
Pennsylvania	8
California	8
New York	6
Massachusetts	5
Ohio	4

Clinical Trial Progress for AMBIEN

Clinical Trial Phase

Clinical Trial Phase for AMBIEN
Clinical Trial Phase	Trials
Phase 4	18
Phase 3	2
Phase 2/Phase 3	2

Clinical Trial Status

Clinical Trial Status for AMBIEN
Clinical Trial Phase	Trials
Completed	40
Not yet recruiting	2
Withdrawn	2

Clinical Trial Sponsors for AMBIEN

Sponsor Name

Sponsor Name for AMBIEN
Sponsor	Trials
Sanofi	6
National Institute of Mental Health (NIMH)	6
National Institutes of Health (NIH)	4

Sponsor Type

Sponsor Type for AMBIEN
Sponsor	Trials
Other	37
Industry	25
U.S. Fed	14